74021-58-2

Basic information

• Product Name: Benzaldehyde, 4-(methoxymethoxy)-3-(3-methyl-2-butenyl)-
• CAS NO: 74021-58-2
• Molecular Formula: C14H18O3
• Molecular Weight: 234.295
• Mol File: 74021-58-2.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 4-(methoxymethoxy)-3-(3-methyl-2-butenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 4-(methoxymethoxy)-3-(3-methyl-2-butenyl)-(74021-58-2)
• EPA Substance Registry System: Benzaldehyde, 4-(methoxymethoxy)-3-(3-methyl-2-butenyl)-(74021-58-2)

Safety Data

• Hazardous Substances Data: 74021-58-2(Hazardous Substances Data)

Upstream product

• 54730-30-2 4-hydroxy-3-C-prenylbenzaldehyde 
• 107-30-2 chloromethyl methyl ether 
• 870-63-3 prenyl bromide 
• 123-08-0 4-hydroxy-benzaldehyde 
• 2973-78-6 3-bromo-4-hydroxybenzylaldehyde 
• 162271-46-7 2-[3-bromo-4-(methoxymethoxy)phenyl]-1,3-dioxolane 
• 162271-15-0 2-bromo-4-(1,3-dioxolan-2-yl)phenol 

Downstream Products

• 405261-81-6 (E)-1-[2-Hydroxy-4-methoxymethoxy-5-(3-methyl-but-2-enyl)-phenyl]-3-[4-methoxymethoxy-3-(3-methyl-but-2-enyl)-phenyl]-propenone 
• 943860-40-0 C₂₃H₂₆O₅ 
• 69964-40-5 6-formyl-2,2-dimethyl-2H-chromene 
• 61370-75-0 3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-6-carboxaldehyde 
• 151135-82-9 (E)-1-<2,4-dihydroxy-3-(3-methyl-2-butenyl)phenyl>-3-<4-hydroxy-3-(3-methyl-2-butenyl)phenyl>-2-propen-1-one 
• 89024-13-5 7,4'-Di(methoxymethoxy)-8,3'-di-(C-prenyl)flavanone 
• 59870-65-4 Glabrol 
• 93766-64-4 5,7,4'-trimethoxymethoxy-3'-prenyl-flavanone 
• 93766-65-5 5,7,4'-trihydroxy-3'-prenyl-flavanone 
• 170662-19-8 5,7-Bis-methoxymethoxy-2-[4-methoxymethoxy-3-(3-methyl-but-2-enyl)-phenyl]-6-(3-methyl-but-2-enyl)-chroman-4-one 
• 93860-22-1 5,7,4'-trihydroxy-3',6-diprenylflavanone 
• 405261-82-7 7-methoxymethoxy-2-[4-methoxymethoxy-3-(3-methyl-but-2-enyl)-phenyl]-6-(3-methyl-but-2-enyl)-chroman-4-one 
• 237769-20-9 2-[4-methoxymethoxy-3-(3-methyl-but-2-enyl)-phenyl]-8,8-dimethyl-2,3-dihydro-8H-pyrano[2,3-f]chromen-4-one 
• 202815-28-9 (E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl)prop-2-en-1-one 

Relevant articles and documents

Flavone acetic acid derivatives, pharmaceutical composition thereof as well as preparation methods and applications of flavone acetic acid derivatives and pharmaceutical composition

The invention belongs to the field of medication chemistry, and relates to flavone acetic acid derivatives, pharmaceutical composition thereof as well as preparation methods and applications of the flavone acetic acid derivatives and the pharmaceutical co

Synthesis and biological evaluation of (±)-abyssinone II and its analogues as aromatase inhibitors for chemoprevention of breast cancer

An efficient and economical synthesis of the naturally occurring aromatase inhibitor abyssinone II was performed. The synthesis features an optimized aromatic prenylation reaction in which an arylcopper intermediate is reacted with prenyl bromide to afford a key intermediate that was converted to a prenylated aromatic aldehyde. Condensation of the aldehyde with an o-hydroxyacetophenone under Claisen-Schmidt conditions afforded a chalcone that was deprotected and cyclized in the presence of sodium acetate in refluxing ethanol to afford (±)-abyssinone II. The synthesis proved to be versatile enough to provide an array of abyssinone II derivatives that were evaluated as aromatase inhibitors. Methylation of the 4′-hydroxyl group of (±)-abyssinone II resulted in a significant increase in aromatase inhibitory activity, and further smaller increases in activity resulted from the methylation of the 7-hydroxyl group and removal of the prenyl side chain. As a result of these structural changes, the most active flavanone of the series was 20 times more potent than (±)-abyssinone II (IC50 40.95 μM).

Syntheses of (+/-)-shinflavanone and its structural analogues as potent inhibitors of bone resorption pits formation.

The first total syntheses of (+/-)-shinflavanone and its structural analogues were achieved. (+/-)-Shinflavanone, appears to be a strong inhibitor of bone resorption pits formation by osteoclast-like cell induced by 1alpha, 25-dihydroxy vitamine D3 (IC50 = 0.70 microg/mL).